As a result, the use of INI, which activates the insulin system in the brain, may be useful for preventing cognitive deficits in patients with DM, as well as for restoring the central insulin-mediated regulation of peripheral metabolism and physiological functions. The gene discussed is INS; the disease is Cognitive impairment.